56 related articles for article (PubMed ID: 23726265)
1. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
[TBL] [Abstract][Full Text] [Related]
2. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Couvelard A; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Rougier P; Penna C; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Ann Oncol; 2012 Sep; 23(9):2327-2335. PubMed ID: 22377565
[TBL] [Abstract][Full Text] [Related]
3. Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.
Tsao MS; Marguet S; Le Teuff G; Lantuejoul S; Shepherd FA; Seymour L; Kratzke R; Graziano SL; Popper HH; Rosell R; Douillard JY; Le-Chevalier T; Pignon JP; Soria JC; Brambilla EM
J Clin Oncol; 2015 Oct; 33(30):3439-46. PubMed ID: 25918286
[TBL] [Abstract][Full Text] [Related]
4. Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.
Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Oláh A; Büchler MW; Greenhalf W;
Br J Cancer; 2018 Apr; 118(8):1084-1088. PubMed ID: 29523831
[TBL] [Abstract][Full Text] [Related]
5. SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.
Anstadt EJ; Carmona R; Berlin E; Yegya-Raman N; Venigalla S; Reddy V; Williams GR; Leibensperger MR; Wojcieszynski A; Baumann BC; Lee MK; Plastaras JP; Furth EE; Mell LK; Metz JM; Ben-Josef E
Cancer; 2024 Feb; 130(3):476-484. PubMed ID: 37823514
[TBL] [Abstract][Full Text] [Related]
6. Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma.
Brugel M; Bouché O; Kianmanesh R; Teuma L; Tashkandi A; Regimbeau JM; Pessaux P; Royer B; Rhaiem R; Perrenot C; Neuzillet C; Piardi T; Deguelte S
BMC Surg; 2021 Dec; 21(1):413. PubMed ID: 34876080
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Serum Sodium Level as a Prognostic and Predictive Biomarker for Adjuvant Therapy in Esophageal Cancer.
Wang Q; Peng L; Han Y; Li T; Dai W; Wang Y; Wu L; Wei Y; Xie T; Fang Q; Li Q; Lang J; Cao B
Front Oncol; 2020; 10():555714. PubMed ID: 33552948
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer.
Yang J; Wan S; Zhao M; Cai H; Gao Y; Wang H
Reprod Sci; 2024 Jan; 31(1):107-121. PubMed ID: 37648942
[TBL] [Abstract][Full Text] [Related]
9. Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma.
Wang B; Xie H; Ma C; Zhang G; Gan H; Wang Q; Liu X; Zhu Y; Zhu Y; Shi G; Zhang H; Dai B; Shen Y; Ye D
J Cancer; 2017; 8(17):3490-3497. PubMed ID: 29151933
[No Abstract] [Full Text] [Related]
10. Unmasking the Hypoxia Landscape in Cervical Cancer: S100A2 and Its Implication for Immunotherapy Resistance.
Laban M; Chen X; Guo B
Reprod Sci; 2024 Jan; 31(1):96-98. PubMed ID: 37653224
[TBL] [Abstract][Full Text] [Related]
11. Real time
Kim DW; Beato F; Kim Y; Tassielli AF; Dai R; Denbo JW; Hodul PJ; Malafa MP; Fleming JB
Oncotarget; 2023 Sep; 14():811-818. PubMed ID: 37713330
[TBL] [Abstract][Full Text] [Related]
12. The impact of Omicron pandemic and COVID-19 vaccination on the pancreatic adenocarcinoma patients.
Fu N; Jiang Y; Xu Z; Yang M; Peng C; Deng X; Zhao S; Shen B
Aging Cancer; 2022; 3(3-4):161-168. PubMed ID: 36718230
[TBL] [Abstract][Full Text] [Related]
13. Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer.
Chon HY; Lee HS; Sung YN; Tae YK; Park CH; Leem G; Kim SJ; Jo JH; Chung MJ; Park JY; Park SW; Hong SM; Bang S
Sci Rep; 2024 Feb; 14(1):2942. PubMed ID: 38316853
[TBL] [Abstract][Full Text] [Related]
14. S100A2 induces epithelial-mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner.
Chen Q; Guo H; Jiang H; Hu Z; Yang X; Yuan Z; Gao Y; Zhang G; Bai Y
Cell Death Discov; 2023 Sep; 9(1):356. PubMed ID: 37758734
[TBL] [Abstract][Full Text] [Related]
15. S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors.
Mandarino A; Thiyagarajan S; Martins ACF; Gomes RDS; Vetter SW; Leclerc E
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627239
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients.
Ali A; Jamieson NB; Khan IN; Chang D; Giovannetti E; Funel N; Frampton AE; Morton J; Sansom O; Evans TRJ; Duthie F; McKay CJ; Samra J; Gill AJ; Biankin A; Oien KA
Am J Cancer Res; 2022; 12(12):5668-5683. PubMed ID: 36628279
[TBL] [Abstract][Full Text] [Related]
17. Influence of S100A2 in Human Diseases.
Sugino H; Sawada Y
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885660
[TBL] [Abstract][Full Text] [Related]
18. Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma.
Ufuk A; Garner T; Stevens A; Latif A
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267606
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
